Prof. Yanming Wang is a professor with nearly 20 years of teaching and research experience in biochemistry, molecular cell biology, epigenetics, innate immunology, and the pathology and treatment of malignant tumors. He has a strong breakthrough in major technology, academic problems of continuous innovation, and achievement transformation ability. He has made remarkable achievements in translational medicine, using the principles of epigenetics to carry out innovative drug research and development, and his research on peptidyl arginine deiminase 4 inhibitors has been authorized by two US patents and one Chinese patent and will further enter preclinical experimental research to realize the social value and economic benefits of his innovative results. The results of his research on targeted antitumor drugs have independent intellectual property rights and are at the international leading level. His research interests include epigenetic regulation of chromatin, cell spinning apoptosis, tumor recurrence and metastasis, congenital immune and autoimmune diseases, and translational medicine.